Correlation Between CalciMedica, Common and Fate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CalciMedica, Common and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CalciMedica, Common and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CalciMedica, Common Stock and Fate Therapeutics, you can compare the effects of market volatilities on CalciMedica, Common and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CalciMedica, Common with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CalciMedica, Common and Fate Therapeutics.

Diversification Opportunities for CalciMedica, Common and Fate Therapeutics

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between CalciMedica, and Fate is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding CalciMedica, Common Stock and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and CalciMedica, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CalciMedica, Common Stock are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of CalciMedica, Common i.e., CalciMedica, Common and Fate Therapeutics go up and down completely randomly.

Pair Corralation between CalciMedica, Common and Fate Therapeutics

Given the investment horizon of 90 days CalciMedica, Common Stock is expected to generate 1.19 times more return on investment than Fate Therapeutics. However, CalciMedica, Common is 1.19 times more volatile than Fate Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  798.00  in CalciMedica, Common Stock on September 24, 2024 and sell it today you would lose (522.00) from holding CalciMedica, Common Stock or give up 65.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy99.8%
ValuesDaily Returns

CalciMedica, Common Stock  vs.  Fate Therapeutics

 Performance 
       Timeline  
CalciMedica, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CalciMedica, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

CalciMedica, Common and Fate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CalciMedica, Common and Fate Therapeutics

The main advantage of trading using opposite CalciMedica, Common and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CalciMedica, Common position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.
The idea behind CalciMedica, Common Stock and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device